Creating a tool to identify men at high risk for HIV in sub-Saharan Africa
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
This study is creating a helpful tool to find men in sub-Saharan Africa who are most at risk of getting HIV, so they can get the right prevention support, like PrEP, to stay healthy.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10762645 on NIH RePORTER |
What this research studies
This research aims to develop a risk assessment tool specifically designed to identify men in sub-Saharan Africa who are at the highest risk of acquiring HIV. By analyzing data from multiple national surveys, the project will utilize rigorous analytic methods to create a tool that can effectively stratify risk among men, ensuring that those most in need of preventive measures like PrEP receive them. The approach focuses on addressing the limitations of existing tools that have primarily been developed for women. Ultimately, this tool will help target HIV prevention efforts more effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are adult men living in sub-Saharan Africa who are at risk of HIV acquisition.
Not a fit: Patients who are not men or those who are not at risk of HIV acquisition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve HIV prevention strategies by ensuring that high-risk men receive timely and appropriate interventions.
How similar studies have performed: Previous research has shown success in developing risk assessment tools for women, but this approach for men is relatively novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Rosenberg, Nora — Univ of North Carolina Chapel Hill
- Study coordinator: Rosenberg, Nora
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.